May 3, 2018 / 8:05 PM / in 3 months

BRIEF-Spectrum Pharmaceuticals Reports Q1 Non-GAAP Loss Per Share $0.15

May 3 (Reuters) - Spectrum Pharmaceuticals Inc:

* SPECTRUM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PIPELINE UPDATE

* Q1 NON-GAAP LOSS PER SHARE $0.15

* Q1 LOSS PER SHARE $0.16

* Q1 REVENUE $30.5 MILLION VERSUS I/B/E/S VIEW $25.7 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.35 — THOMSON REUTERS I/B/E/S

* COMPANY HAS ALSO RAISED GUIDANCE FOR 2018

* EXPECTS ITS CURRENT CASH AND MARKETABLE SECURITIES TO BE SUFFICIENT TO FUND OPERATIONS INTO 2020

* COMPANY EXPECTS ITS CURRENT CASH AND MARKETABLE SECURITIES TO BE SUFFICIENT TO FUND OPERATIONS INTO 2020

* FY2018 REVENUE VIEW $105.1 MILLION — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below